News | October 21, 2009

Cook Unveils Integrated Line Peripheral Arterial Disease Devices

The Zilver 518 RX is a self-expanding nitinol stent.

October 21, 2009 – Cook Medical is introducing six new products in parallel to provide better treatment options to treat peripheral arterial disease (PAD), including new microwires, stents and angioplasty balloons that are integral to Cook’s advanced Leg Therapy Program.

Cook said the program offers the industry’s broadest line of products engineered specifically to address the dynamic circulation of the iliac, femoral, popliteal and infrapopliteal vascular systems. In addition, Cook will introduce a new thoracic aneurysm endograft and a sophisticated new delivery and retrieval system for Cook’s inferior vena cava filters for pulmonary embolism prevention to physicians attending VIVA 2009 in Las Vegas.

The company said its Approach CTO microwires, the first .014-inch wires designed specifically for crossing chronic total occlusions and extremely tight lesions in the peripheral arteries. The Advance line of balloon dilatation catheters comprises three low-profile balloons (14LP, 18LP, 35LP) that range in size and composition to treat lesions in the peripheral arteries (from the femoral through the popliteal and into the infrapopliteal region). Each balloon features a low crossing profile and small-sheath compatibility, which helps reduce the need for an invasive arterial entry and may shorten patient recovery time. Used as an adjunct to percutaneous transluminal angioplasty in the iliac, the Zilver 518 RX is a self-expanding nitinol stent with rapid exchange capabilities that ensure accuracy.

In addition to its new PAD products, at VIVA 2009 in booth 150, Cook also will have cutting-edge products on display to improve the prognosis of individuals with abdominal aortic aneurysm or pulmonary embolism. The Zenith TX2 Pro-Form endograft, engineered especially for procedures in which the product must be positioned in tight aortic arches, utilizes an improved delivery system that allows for carefully controlled deployment of the endograft to help establish proximal conformity of the device to the aortic wall. The new NavAlign IVC filter delivery system, introduced last month for both the Cook Celect and Günther Tulip filters, is designed to minimize trauma and streamline filter placement with easy jugular access.

For more information:,

Related Content

Edwards Lifesciences Recalls IntraClude Intra-aortic Occlusion Device
News | Balloon Catheter | July 15, 2019
Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon rupture during...
Gore Molding & Occlusion Balloon for Endovascular Aortic Repair Receives FDA Approval
Technology | Balloon Catheter | August 23, 2018
W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore...
Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init